 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
ESA NewsESA Newsletter: November 2002 SIGNIFICANT MEMBER HONOURS Richard Larkins
Richard has been Dean of the Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne since 1998. Before becoming Dean, he held the James Stewart Chair of Medicine at Royal Melbourne Hospital from 1984 to 1997. Other appointments held by Professor Larkins have included Chair of the National Health and Medical Research Council of Australia (1997 to 2000), President of the Royal Australasian College of Physicians (2000-2002) member of the Prime Minister's Science, Engineering and Innovation Council (1997 to 2000), member of the National Aboriginal and Torres Strait Islander Health Council (1997 to 2000), Chairman of the Accreditation Committee of the Australian Medical Council (1991 to 1995) and President of the Endocrine Society of Australia (1982 to 1984). His research and clinical work are in diabetes and endocrinology. Congralulations, Richard! (photo: Richard Larkins.jpg). Richard Pestell
(from Georgetown University press release) << Table of Contents - ESA Newsletter: November 2002
|
The
ESA was very pleased to learn that Professor Richard Larkins was made an Officer
of the Order of Australia (AO) in the recent Queen's Birthday Honours List, "
for "service to medicine and health as an advocate for increased investment
in research, as a contributor to health policy reform, and as an initiator of
innovative medical programmes and the provision of training opportunities for
medical officers in the Oceania region". 
Georgetown
University Medical Center and Georgetown University Hospital have announced the
appointment of Richard G. Pestell, MD, PhD, as director of the Lombardi Cancer
Center, effective September 3, 2002. Dr.Pestell, an internationally renowned expert
in oncology and endocrinology, comes to Georgetown from the Albert Einstein College
of Medicine at Yeshiva University. He is a highly respected researcher and clinician
whose current work is focused on developing new cancer therapies that specifically
target tumors, and reduce the side effects that are associated with commonly used
cancer treatments such as chemotherapy and radiation. The author of more than
150 research papers and reviews, and 130 research abstracts, Dr. Pestell has consistently
published in leading journals including Cell, Science, and Nature Medicine. He
has an outstanding record of obtaining funding, including five projects currently
funded by the National Institutes of Health, and is the head of an inter-institutional
grant funded by the Department of Defense. Dr. Pestell was most recently chair
of the Division of Endocrine-Dependent Tumor Biology at Albert Einstein Cancer
Center at Yeshiva University. He received his MD and PhD degrees from the University
of Melbourne, Australia. 
